Identification of novel genetic etiology and key molecular pathways for seminoma via network-based studies

Yuanlei Chen1, Chao Qi2, Liqun Xia1

  • 1Department of Urology and Chawnshang Chang Liver Cancer Center, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.

Insights

This study identifies key genes in seminoma, a common testicular cancer. These identified hub genes offer potential for new diagnostic biomarkers and therapeutic targets for seminoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Seminoma is the most frequent testicular malignant germ cell tumor, posing a significant threat to male reproductive health.
  • The precise pathogenesis and progression mechanisms of seminoma remain largely unelucidated, with limited research focused on its underlying molecular mechanisms.

Purpose of the Study:

  • To identify gene signatures converging on molecular pathways driving core cancer characteristics in seminoma.
  • To uncover potential diagnostic biomarkers and therapeutic targets for seminoma through gene expression analysis.

Main Methods:

  • Downloaded gene expression profiles (GSE18155) from the GEO database to identify differentially expressed genes (DEGs).
  • Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses using DAVID.
  • Constructed a protein-protein interaction (PPI) network with Cytoscape to identify top 10 hub genes and analyzed subnetworks using the MCODE plugin.

Main Results:

  • Identified 3,502 DEGs, comprising 1,563 upregulated and 1,939 downregulated genes.
  • The top 10 hub genes identified include Ubc, Ubb, Mapk8, Ar, Pten, Cdk2, Cdk4, Rac1, Top2a, and Cdkn1a.
  • Hub genes are implicated in significant molecular pathways such as ERBB2 signaling, pathways in cancer, PI3K-AKT signaling, and the cell cycle.

Conclusions:

  • The identified hub genes enhance the understanding of the genetic etiology and molecular mechanisms in seminoma development.
  • These hub genes represent promising candidates for diagnostic biomarkers and therapeutic molecular targets for seminoma.